Drug · DIN 02351528
YONDELIS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 24, 2020; first marketed August 5, 2010.
- Drug Identification Number (DIN)
- 02351528
- Company (DIN owner)
- Valeo Pharma Inc.Oakville, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Trabectedin L01CX01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRABECTEDIN | 1 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 2, 2020: NOC 23705New Drug Submission (NDS) · Administrative: Change in Product Ownership
- September 23, 2016: NOC 18508Supplement to a New Drug Submission (SNDS) · Update to the product monograph with safety information as recommended in health canada's advisement letter dated may 12, 2016
- May 13, 2010: NOC 11372New Drug Submission (NDS)